1994
DOI: 10.1016/0022-1759(94)90134-1
|View full text |Cite
|
Sign up to set email alerts
|

Purification of human IgG4 subclass with allergen-specific blocking activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

1996
1996
2011
2011

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 0 publications
0
7
0
Order By: Relevance
“…The functional role of allergen‐specific inhibitory IgG 1 and IgG 4 antibodies has been demonstrated in other studies. Using monoclonal Bet v 1–specific IgG 1 and polyclonal IgG 1 and IgG 4 antibodies, these antibodies inhibited basophil histamine release in SIT‐treated patients (9, 26, 27). The possible mechanisms of how grass pollen–specific IgG 1 and IgG 4 antibody subclasses contribute towards desensitization are not very well understood.…”
Section: Discussionmentioning
confidence: 99%
“…The functional role of allergen‐specific inhibitory IgG 1 and IgG 4 antibodies has been demonstrated in other studies. Using monoclonal Bet v 1–specific IgG 1 and polyclonal IgG 1 and IgG 4 antibodies, these antibodies inhibited basophil histamine release in SIT‐treated patients (9, 26, 27). The possible mechanisms of how grass pollen–specific IgG 1 and IgG 4 antibody subclasses contribute towards desensitization are not very well understood.…”
Section: Discussionmentioning
confidence: 99%
“…Although hampered by the lack of pure allergens for the investigation of blocking antibodies, attempts have been made to measure blocking antibody responses (18–20). IgG antibody measurement performed with allergen extracts cannot discriminate between IgG antibodies specific for non‐allergenic components and allergens.…”
Section: Discussionmentioning
confidence: 99%
“…It has been demonstrated by several investigators that SIT‐induced IgG in individual patients can inhibit histamine release (HR) from basophils in vitro [20–23]. Similarly, blocking of HR has been shown with monoclonal human Bet v 1‐specific IgG1 [24].…”
Section: Introductionmentioning
confidence: 99%